BellaSeno granted market access in Europe for bone scaffolds

BellaSeno, an ISO 13485-certified medtech company developing resorbable scaffolds using additive manufacturing technologies, has announced that the company has received authorisation for its custom-made bone and pectus excavatum scaffolds in Europe under EU medical devices regulations.

The custom-made pectus excavatum scaffolds are among the first 3D-printed regenerative medicine products for surgical use within the plastic and reconstructive surgical field. BellaSeno leverages its additive manufacturing platform for producing a broad variety of medical scaffolds and implants. The company has already demonstrated superior mechanical properties of its medical scaffolds, most recently at the European EFORT Congress. BellaSeno's fully automated no-touch manufacturing process allows for high scalability, personalised product characteristics and patient safety.

"We are excited about gaining European market access for our custom-made bone and pectus excavatum scaffolds," said Mohit Chhaya, CEO of BellaSeno. "Clinical data from patients who have received the scaffolds have been very encouraging to date. We are now seeking market authorisations in other geographic regions and for additional products, such as our off-the-shelf breast implants that are suitable for both breast reconstruction and plastic surgery. Our goal is to become a diversified portfolio company and our versatile and sophisticated manufacturing infrastructure puts us in an excellent position to achieve this goal."

"The initial results from the first patients demonstrate that our resorbable implants are safe, well tolerated and increase the potential of autologous tissue grafts," said Dr. med. Tobias Grossner, chief medical officer of BellaSeno. "We are convinced that our approach bears the potential for a paradigm change in regenerative surgery, a field that is in need of innovation to restore complex three-dimensional structures."

BellaSeno's ISO 13485 certified manufacturing platform is designed to meet the requirements of medical scaffolds ranging from soft tissue to bone and enables the production of both custom-made and off-the-shelf sterile medical implants.